CodeSystem Comparison between http://loinc.org vs http://loinc.org

Messages

Metadata

Name	Value		Comments
caseSensitive	true
compositional
content	complete
copyright
date	2024-10-15T11:00:36+02:00	2024-12-18T16:40:01+01:00	Values Differ
description	All LOINC codes from `http://loinc.org` used in this IG. Provided so the FHIR server can perform expansions.
experimental	true
hierarchyMeaning
jurisdiction
jurisdiction[0]	http://unstats.un.org/unsd/methods/m49/m49.htm#001
name	WHODDCCloinc
publisher	WHO
purpose
status	draft	active	Values Differ
title	LOINC codes used in this IG
url	http://loinc.org
version	1.0.0	1.0.1	Values Differ
versionNeeded

Concepts

Code	Display		Comments
LP6464-4	Nucliec acid amplification with probe detection
LP217198-3	Rapid immunoassay
100861-4	Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
100858-0	Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
100862-2	Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
100859-8	Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
100863-0	Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
100860-6	Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
96766-1	GISAID sequence accession number
95942-9	Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
97099-6	Influenza virus A and B and SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
95941-1	Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory specimen by NAA with probe detection
95380-2	Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection
95423-0	Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory specimen by NAA with probe detection
95422-2	Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection
100345-8	Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
98733-9	Percent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay
99771-8	SARS coronavirus 2 spike and nucleocapsid protein stimulated gamma interferon panel - Blood
98846-9	SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells [Units/volume] corrected for background in Blood by Immunoassay
98847-7	SARS coronavirus 2 stimulated gamma interferon release by lymphocytes [Units/volume] corrected for background in Blood by Immunoassay
99774-2	SARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count [#] corrected for background in Blood
99773-4	SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count [#] corrected for background in Blood
95209-3	SARS-CoV+SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
94763-0	SARS-CoV-2 (COVID-19) [Presence] in Specimen by Organism specific culture
94661-6	SARS-CoV-2 (COVID-19) Ab [Interpretation] in Serum or Plasma
95825-6	SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay
98069-8	SARS-CoV-2 (COVID-19) Ab [Presence] in Saliva (oral fluid) by Rapid immunoassay
94762-2	SARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay
95542-7	SARS-CoV-2 (COVID-19) Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
94769-7	SARS-CoV-2 (COVID-19) Ab [Units/volume] in Serum or Plasma by Immunoassay
96118-5	SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay
94503-0	SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay
94558-4	SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
96119-3	SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
97097-0	SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
96094-8	SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection
98080-5	SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Saliva (oral fluid) by NAA with probe detection
96896-6	SARS-CoV-2 (COVID-19) clade [Type] in Specimen by Molecular genetics method
96764-6	SARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
96763-8	SARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory specimen by NAA with probe detection
94562-6	SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
94768-9	SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
95427-1	SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence
94720-0	SARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
95125-1	SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay
96742-2	SARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay
94761-4	SARS-CoV-2 (COVID-19) IgG Ab [Presence] in DBS by Immunoassay
94563-4	SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
94507-1	SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
95429-7	SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
94505-5	SARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
94547-7	SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay
95416-4	SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay
94564-2	SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay
94508-9	SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
95428-9	SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence
94506-3	SARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
96895-8	SARS-CoV-2 (COVID-19) lineage [Identifier] in Specimen by Molecular genetics method
100157-7	SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing
96957-6	SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection
95521-1	SARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection
96898-2	SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
94510-5	SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by NAA with probe detection
94311-8	SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N1
94312-6	SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N2
95522-9	SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection
94760-6	SARS-CoV-2 (COVID-19) N gene [Presence] in Nasopharynx by NAA with probe detection
96986-5	SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection
95409-9	SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection
94533-7	SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by NAA with probe detection
94756-4	SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1
94757-2	SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N2
95425-5	SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection
96448-6	SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1
96958-4	SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2
94766-3	SARS-CoV-2 (COVID-19) N gene [Presence] in Serum or Plasma by NAA with probe detection
94316-7	SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by NAA with probe detection
94307-6	SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N1
94308-4	SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N2
99596-9	SARS-CoV-2 (COVID-19) N protein IgG Ab [Presence] in Serum or Plasma by Immunoassay
95411-5	SARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT
95410-7	SARS-CoV-2 (COVID-19) neutralizing antibody [Titer] in Serum by pVNT
97098-8	SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection
98132-4	SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory specimen by NAA with probe detection
98494-8	SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Saliva (oral fluid) by NAA with probe detection
96899-0	SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
94644-2	SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
94511-3	SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Specimen by NAA with probe detection
94559-2	SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection
95824-9	SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection
94639-2	SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Specimen by NAA with probe detection
97104-4	SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection
98131-6	SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory specimen by NAA with probe detection
98493-0	SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Saliva (oral fluid) by NAA with probe detection
94646-7	SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
94645-9	SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Specimen by NAA with probe detection
96120-1	SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection
94534-5	SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Respiratory specimen by NAA with probe detection
96091-4	SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection
94314-2	SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Specimen by NAA with probe detection
96123-5	SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection
99314-7	SARS-CoV-2 (COVID-19) RdRp gene mutation detected [Identifier] in Specimen by Molecular genetics method
94745-7	SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
94746-5	SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Specimen by NAA with probe detection
94819-0	SARS-CoV-2 (COVID-19) RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
94565-9	SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with non-probe detection
94759-8	SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
95406-5	SARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection
96797-6	SARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection
95608-6	SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with non-probe detection
94500-6	SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with probe detection
95424-8	SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing
94845-5	SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
94822-4	SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by Sequencing
94660-8	SARS-CoV-2 (COVID-19) RNA [Presence] in Serum or Plasma by NAA with probe detection
94309-2	SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection
96829-7	SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection
96897-4	SARS-CoV-2 (COVID-19) RNA panel - Oropharyngeal wash by NAA with probe detection
94531-1	SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection
95826-4	SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection
94306-8	SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
96900-6	SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
94642-6	SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
94643-4	SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Specimen by NAA with probe detection
94640-0	SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by NAA with probe detection
95609-4	SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by Sequencing
96765-3	SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection
94767-1	SARS-CoV-2 (COVID-19) S gene [Presence] in Serum or Plasma by NAA with probe detection
94641-8	SARS-CoV-2 (COVID-19) S gene [Presence] in Specimen by NAA with probe detection
96752-1	SARS-CoV-2 (COVID-19) S gene mutation [Presence] in Specimen by Molecular genetics method
96751-3	SARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method
99597-7	SARS-CoV-2 (COVID-19) S protein IgG Ab [Presence] in Serum or Plasma by Immunoassay
96603-6	SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by sVNT
98732-1	SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Titer] in Serum or Plasma by Immunoassay
98734-7	SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Units/volume] in Serum or Plasma by Immunoassay
96894-1	SARS-CoV-2 (COVID-19) sequencing and identification panel - Specimen by Molecular genetics method
95970-0	SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing
100156-9	SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection
96741-4	SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing
96755-4	SARS-CoV-2 (COVID-19) variant interpretation in Specimen Narrative
94764-8	SARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing
99772-6	SARS-CoV-2 stimulated gamma interferon [Interpretation] in Blood Qualitative
95971-8	SARS-CoV-2 stimulated gamma interferon [Presence] in Blood
95974-2	SARS-CoV-2 stimulated gamma interferon panel - Blood
95972-6	SARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood
95973-4	SARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood
94509-7	SARS-related coronavirus E gene [Cycle Threshold #] in Specimen by NAA with probe detection
96121-9	SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection
94758-0	SARS-related coronavirus E gene [Presence] in Respiratory specimen by NAA with probe detection
95823-1	SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection
94765-5	SARS-related coronavirus E gene [Presence] in Serum or Plasma by NAA with probe detection
94315-9	SARS-related coronavirus E gene [Presence] in Specimen by NAA with probe detection
96122-7	SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection
94313-4	SARS-related coronavirus N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N3
94310-0	SARS-related coronavirus N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N3
94502-2	SARS-related coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection
94647-5	SARS-related coronavirus RNA [Presence] in Specimen by NAA with probe detection
94532-9	SARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection
98062-3	Sequencing study identifier
100342-5	Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry
82593-5	Immunization summary report
11369-6	History of Immunization Narrative
30954-2	Relevant diagnostic tests/laboratory data Narrative
30980-7	Date vaccine due